Article Details
Retrieved on: 2025-03-20 14:02:31
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Roche's discontinued Alzheimer's drug, gantenerumab, showing potential in delaying cognitive symptoms, with OLE study data highlighting its impact on genetic Alzheimer's onset. It relates to tags on Alzheimer's treatments and research advancements.
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here